Professor Guy Thwaites, Director of OUCRU, honoured for contributions to Vietnam’s healthcare sector
Over his 13-year tenure as Director of the Oxford University Clinical Research Unit (OUCRU) in Ho Chi Minh City, Professor Guy Edward Thwaites has played a significant role in enhancing Vietnam’s healthcare sector’s standing on the global medical map.
OUCRU trials AI-powered wearables for early warning of severe dengue
AI applications in dengue monitoring and prediction are showing encouraging early signals, with new models achieving around 80% accuracy in forecasting severe progression up to two hours in advance. The Oxford University Clinical Research Unit (OUCRU) presented these findings at the Dengue Summit 2025, organised by Ho Chi Minh City Pasteur Institute.
OUCRU awarded prestigious Wellcome Discovery Awards grant to advance tuberculosis research
The Tuberculosis research team at OUCRU has received a £3.8 million grant to investigate why some people with tuberculosis respond better to treatment than others; and how to improve survival from its deadliest form, tuberculous meningitis.
MODRA Cohort 2: From ideas to action
Following the success of the first MODRA workshop in September, where participants developed strong research grant proposals, the MODRA Cohort 2 researchers reconvened at OUCRU Ho Chi Minh City for Workshop 2, focused on taking their projects from paper to practice.
OUCRU contributes to defining the first core outcome measurement set for Dengue
A major international collaboration between ISARIC researchers at King’s College London and the Oxford University Clinical Research Trials Unit (OUCRU) has created the first global Core Outcome Measurement Set (COMS) for dengue clinical trials.
OUCRU workshop drives dialogue on early warning systems for climate-sensitive infectious diseases
Researchers, policymakers, and health professionals gathered at the Oxford University Clinical Research Unit (OUCRU) for a workshop on “Enablers and Barriers to Development and Implementation of Early Warning and Response Systems for Climate-Sensitive Infectious Diseases in Viet Nam.”
OUCRU alumnus appointed as new Director of Children’s Hospital 1, Ho Chi Minh City
Dr Ngô Ngọc Quang Minh, an OUCRU PhD graduate, has been appointed as the new Director of Children’s Hospital 1, the leading paediatric referral hospital for Ho Chi Minh City and southern Viet Nam. His appointment was announced by the Ho Chi Minh City Department of Health and takes effect from 1 October 2025.
MODRA Cohort 2 begins: Empowering the next generation of leaders in global health
Fifteen emerging scientists from South and Southeast Asia begin an 18-month journey with MODRA. Together, they are gaining the skills to lead research that makes a difference in global health.
New study maps immune cells fuelling harmful inflammation in tuberculous meningitis
Tuberculous meningitis harms not only through infection, but also through the body’s own overactive immune response. Using single-cell RNA sequencing, OUCRU scientists have identified specific immune cells in the brain that may be driving this harmful inflammation. Their study established a cutting-edge cellular method to identify new therapeutic targets for host-directed therapy, aimed at improving survival and reducing immune-mediated brain injury in TBM patients.
OUCRU scientists awarded professorship by University of Oxford
Three senior researchers at OUCRU Vietnam, Lê Văn Tấn, C. Louise Thwaites, and Timothy Walker, have been conferred the title of full Professor by the University of Oxford. This recognition reflects their exceptional contributions to global health research and their leadership within OUCRU and beyond.
What I learned as a UK clinical intern at OUCRU Vietnam: infectious diseases and the realities of vaccine inequality
Hello, I’m Nandita Shenolikar and I am a final-year medical student from the UK. If you’ve been around OUCRU Ho Chi Minh City in the last few months, you’ve probably seen me and some other British medical students in the building.
Policy in action: A Princeton student’s internship at OUCRU Vietnam
Hello! My name is Alayshja Bable and I am a rising senior at Princeton University. This summer, I joined OUCRU Vietnam’s Policy Engagement team in Ho Chi Minh City, where I explored how health research connects with people and policy on the ground.
15 emerging Asian global health researchers selected to join MODRA
The MORU – OUCRU Discovery Research Academy (MODRA) announces its 2025 cohort of emerging researchers in global health and infectious diseases.
EQUIPSEA
WHO delegation visits OUCRU to strengthen collaboration on infectious disease research and surveillance
Oxford University Clinical Research Unit (OUCRU) and the Hospital for Tropical Diseases (HTD) in Ho Chi Minh City recently welcomed a delegation from the World Health Organisation (WHO) as part of efforts to strengthen technical collaboration in infectious disease preparedness and response.
Dr Ho Quang Chanh appointed Head of Dengue Research Group at OUCRU
We are pleased to announce the appointment of Dr Ho Quang Chanh as the new Head of the Dengue Research Group at the Oxford University Clinical Research Unit.
AI and big data in clinical care for infectious diseases in Vietnam
Oxford University Clinical Research Unit (OUCRU) and the Hospital for Tropical Diseases in Ho Chi Minh City recently hosted a scientific conference titled “Applying Artificial Intelligence and Big Data in Clinical Practice for Infectious Diseases.”
OUCRU and partners chart a “Roadmap to the Future of Clinical Trials in Vietnam”
OUCRU, Pharma Group, and KPMG have jointly launched the “Roadmap to the Future of Clinical Trials in Vietnam” report.
Celebrating OUCRU’s PhD graduates and welcoming new scholars
Each year, OUCRU celebrates the achievements of its PhD graduates and welcomes a new cohort of scholars embarking on impactful research in infectious diseases and public health.
Innovative study identifies more effective and affordable treatment strategies for Hepatitis C
The Oxford University Clinical Research Unit (OUCRU) announced promising results from the VIETNARMS trial, a years-long multi-arm clinical trial conducted in Vietnam. The results offer important insights into new treatment regimens for Hepatitis C, potentially reducing treatment durations and halving treatment costs.